Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (4862)	11/6/2003 10:38:52 PM
From: StockDung	Read Replies (1) \| Respond to of 5582

If they are so different, then why do they compare the efficacy of the two in their own FAQs, Dan???

To: DanZ who wrote (4862)	11/8/2003 3:59:21 PM
From: StockDung	Respond to of 5582

"Id. at 9-10 (emphasis in original). Similarly, Mr. Eby also says, "Furthermore, the inventor has on various occasions tested a zinc gluconate spray intranasaly [sic], and it was not found to be effective in cold treatment." Id. at 5. In a separate, later declaration, Mr. Eby stated to the examiner that his early experiments in the area had included use of a "zinc gluconate nasal spray solution[]" and that these had resulted in "extreme nasal pain." George Andrew Eby III Declaration dated December 13, 1988 at 5." web.archive.org